Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US10370407B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10370407-B2 |
| Application number | US-201615545459-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2016 |
| Priority date | Jan 21, 2015 |
| Publication date | Aug 6, 2019 |
| Grant date | Aug 6, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for preparing a protein conjugate having a defined number of conjugate groups are provided. The method includes: forming a mixture containing a macrocyclic matrix material and a plurality of proteins; eluting the proteins to obtain a first separated protein fraction and a second separated protein fraction, wherein substantially all of the proteins in the first separated protein fraction have the same number of handle moieties; contacting the handle moieties with a conversion reagent under conditions sufficient to convert the handle moieties in the first separated protein fraction to reactive moieties; and contacting the reactive moieties with a conjugation reagent under conditions sufficient to form a plurality of protein conjugates, wherein substantially all of the protein conjugates in the plurality have the same number of conjugate groups. Methods also include recovering enzymes and other proteins from mixtures for isolation and/or reuse of the enzymes and proteins.
Opening claim text (preview).
What is claimed is: 1. A method for preparing a protein conjugate having a defined number of conjugate groups, the method comprising: i) forming a mixture comprising a cyclodextrin matrix material and a plurality of proteins, wherein: each protein in a first population of proteins in the plurality comprises a first number of handle moieties, each protein in a second population of proteins in the plurality comprises a second number of handle moieties, the first number of handle moieties and the second number of handle moieties are at least one and differ from one another, and the mixture is formed under conditions sufficient to bind the modified proteins to the cyclodextrin matrix material; ii) eluting the proteins from the cyclodextrin matrix material to obtain a first separated protein fraction and a second separated protein fraction, wherein: substantially all of the proteins in the first separated protein fraction comprise the first number of handle moieties, and substantially all of the proteins in the second separated protein fraction comprise the second number of handle moieties; iii) contacting the handle moieties with a conversion reagent under conditions sufficient to convert the handle moieties in the first separated protein fraction to reactive moieties; and iv) contacting the reactive moieties with a conjugation reagent under conditions sufficient to form a plurality of protein conjugates, wherein substantially all of the protein conjugates in the plurality have the same number of conjugate groups; thereby preparing the protein conjugate wherein the handle moieties comprise a structure according to Formula I: or a salt thereof, wherein m is an integer ranging from 0 to 5; each R 1 is independently selected from the group consisting of —OR a , —N(R a ) 3 , —SO 3 H, and —CO 2 H; R 2 is selected from the group consisting of H and —OR a ; each R a is independently selected from the group consisting of H and C 1-6 alkyl; and L 1 is a linking moiety. 2. The method of claim 1 , wherein the handle moiety comprises a structure according to Formula Ia: or a salt thereof, wherein m is an integer ranging from 0 to 5; each R 1 is independently selected from the group consisting of —OR a , —N(R a ) 3 , —SO 3 H, and —CO 2 H, wherein each R a is independently selected from the group consisting of H and C 1-6 alkyl; and L 1 is a linking moiety. 3. The method of claim 1 , wherein the linking moiety comprises a structure selected from the group consisting of: wherein L 1a and L 1b are independently selected from the group consisting of a bond, a divalent polymer moiety, and linear or branched, saturated or unsaturated C 1-30 alkyl; wherein one or more carbon atoms in the C 1-30 alkyl is optionally and independently replaced by O, S, NW; wherein two or more groupings of adjacent carbon atoms in the C 1-30 alkyl are optionally and independently replaced by —NR a (CO)— or —(CO)NR a —; and wherein two or more groupings of adjacent carbon atoms in the C 1-30 alkyl are optionally and independently replaced by a 4- to 8-membered, divalent carbocycle or a 4- to 8-membered, divalent heterocycle having one to four heteroatoms selected from the group consisting of O, S, and N; each R a is independently selected from the group consisting of H and C 1-6 alkyl; the wavy line represents the point of connection to the protein; and the dashed line represents the point of connection to the structure of Formula I. 4. The method of claim 1 , wherein the reactive moiety comprises a structure according to Formula II: 5. The method of claim 1 , wherein the reactive moiety comprises a structure according to Formula IIa: 6. The method of claim 2 , wherein the conjugation reagent comprises a structure according to Formula III: wherein: R 3 is selected from the group consisting of —N(R a ) 2 and —OR a ; R 4 is selected from the group consisting of —OR a , C 1-6 alkyl, —N(R a ) 2 , —N 3 , and —NH(CO)R a ; subscript n is an integer ranging from 0 to 3; each R a is independently selected from the group consisting of H and C 1-6 alkyl; L 2 is a linking moiety; and A is a prosthetic moiety. 7. The method of claim 6 , wherein the conjugation reagent comprises a structure according to Formula Ma: wherein L 2a and L 2b are independently selected from the group consisting of a bond, a divalent polymer moiety, and linear or branched, saturated or unsaturated C 1-30 alkyl; wherein one or more carbon atoms in the C 1-30 alkyl is optionally and independently replaced by O, S, NW; wherein two or more groupings of adjacent carbon atoms in the C 1-30 alkyl are optionally and independently replaced by —NR a (CO)— or —(CO)NR a —; and wherein two or more groupings of adjacent carbon atoms in the C 1-30 alkyl are optionally and independently replaced by a 4- to 8-membered, divalent carbocycle or a 4- to 8-membered, divalent heterocycle having one to four heteroatoms selected from the group consisting of O, S, and N; and each R a is independently selected from the group consisting of H and C 1-6 alkyl. 8. The method of claim 1 , wherein the contacting is conducted in the presence of an oxidizing agent, wherein the oxidizing agent is potassium ferricyanide. 9. The method of claim 6 , wherein the protein conjugate comprises a structure according to Formula IV: 10. The method of claim 1 , wherein the cyclodextrin matrix material comprises a plurality of cyclodextrin moieties, wherein the cyclodextrin moiety comprises a structure according to Formula VI: wherein L 3 is a linking moiety, and the wavy line represents the connection point to the matrix material. 11. The method of claim 10 , wherein the linking moiety comprises the grouping L 3a -L 3b -, wherein L 3a and L 3b independently selected from the group consisting of a bond, a divalent polymer moiety, and linear or branched, saturated or unsaturated C 1-30 alkyl; wherein one or more carbon atoms in the C 1-30 alkyl is optionally and independently replaced by O, S, NW; wherein two or more groupings of adjacent carbon atoms in the C 1-30 alkyl are optionally and independently replaced by —NR a (CO)— or —(CO)NR a —; and wherein two or more groupings of adjacent carbon atoms in the C 1-30 alkyl are optionally and independently replaced by a 4- to 8-membered, divalent carbocycle or a 4- to 8-membered, divalent heterocycle having one to four heteroatoms selected from the group consisting of O, S, and N; and each R a is independently selected from the group consisting of H and C 1-6 alkyl. 12
by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids · CPC title
Macromolecular products derived from proteins (food proteins A23; glue, gelatine C09H) · CPC title
Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof · CPC title
Labelling of peptides · CPC title
Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.